Invesaro

Stocks Comparison

Cooper Companies vs RxSight: revenue, profit, margins and growth compared

Cooper Companies brought in $4.1B of revenue in fiscal 2025, RxSight $134.5M in fiscal 2025. Revenue changed by +5.1% at Cooper Companies and -3.9% at RxSight on the year before, so Cooper Companies grew faster. Cooper Companies kept 9.2% of its revenue as net profit, RxSight -29.0%. Free cash flow was $433.7M at Cooper Companies and -$19.3M at RxSight.

Side by side, latest fiscal year

COORXST
Fiscal year endedFY2025 (October 31, 2025)FY2025 (December 31, 2025)
Revenue$4.1B$134.5M
Revenue growth+5.1%-3.9%
Net income$374.9M-$38.9M
Net margin9.2%-29.0%
Free cash flow$433.7M-$19.3M
Free cash flow margin10.6%-14.4%
Earnings per share (diluted)$1.87-$0.95
Cash$110.6M$19.9M
Debt$2.5Bn/a
Price to earnings29.6n/a
Market value$10.8B$193.8M
Dividend yieldn/an/a
Rank by revenue in sector#70 of 523 · Health care#279 of 523 · Health care

Over the years

Revenue
COO FY2018: $2.5BCOO FY2019: $2.7BCOO FY2020: $2.4BCOO FY2021: $2.9BCOO FY2022: $3.3BCOO FY2023: $3.6BCOO FY2024: $3.9BCOO FY2025: $4.1BRXST FY2021: $14.7MRXST FY2021: $22.6MRXST FY2022: $49MRXST FY2023: $89.1MRXST FY2024: $139.9MRXST FY2025: $134.5MFY18FY19FY20FY21FY22FY23FY24FY25
COO $4.1BRXST $134.5M
Net income
COO FY2018: $139.9MCOO FY2019: $466.7MCOO FY2020: $238.4MCOO FY2021: $2.9BCOO FY2022: $385.8MCOO FY2023: $294.2MCOO FY2024: $392.3MCOO FY2025: $374.9MRXST FY2021: $27.6MRXST FY2021: -$48.7MRXST FY2022: -$66.8MRXST FY2023: -$48.6MRXST FY2024: -$27.5MRXST FY2025: -$38.9MFY18FY19FY20FY21FY22FY23FY24FY25
COO $374.9MRXST -$38.9M
Net margin
COO FY2018: 5.5%COO FY2019: 17.6%COO FY2020: 9.8%COO FY2021: 100.8%COO FY2022: 11.7%COO FY2023: 8.2%COO FY2024: 10.1%COO FY2025: 9.2%RXST FY2021: 187.9%RXST FY2021: -215.5%RXST FY2022: -136.2%RXST FY2023: -54.6%RXST FY2024: -19.6%RXST FY2025: -29.0%FY18FY19FY20FY21FY22FY23FY24FY25
COO 9.2%RXST -29.0%
Revenue growth
COO FY2019: +4.8%COO FY2020: -8.4%COO FY2021: +20.2%COO FY2022: +13.2%COO FY2023: +8.6%COO FY2024: +8.4%COO FY2025: +5.1%RXST FY2021: +53.9%RXST FY2022: +116.9%RXST FY2023: +81.8%RXST FY2024: +57.1%RXST FY2025: -3.9%FY19FY20FY21FY22FY23FY24FY25
COO +5.1%RXST -3.9%
Free cash flow
COO FY2018: $475.3MCOO FY2019: $421.1MCOO FY2020: $176.2MCOO FY2021: $524.2MCOO FY2022: $450.4MCOO FY2023: $215MCOO FY2024: $288.1MCOO FY2025: $433.7MRXST FY2021: -$37.7MRXST FY2021: -$46.6MRXST FY2022: -$61.2MRXST FY2023: -$46.4MRXST FY2024: -$22.4MRXST FY2025: -$19.3MFY18FY19FY20FY21FY22FY23FY24FY25
COO $433.7MRXST -$19.3M

Fiscal years as each company reports them; the two may end in different months.

Questions about Cooper Companies and RxSight

Which is bigger by revenue, Cooper Companies or RxSight?

Cooper Companies is bigger by revenue: $4.1B in fiscal 2025, against $134.5M for RxSight in fiscal 2025.

Which keeps more of its revenue as profit, Cooper Companies or RxSight?

Cooper Companies had a net margin of 9.2% in fiscal 2025; RxSight had -29.0% in fiscal 2025.

Which grew revenue faster, Cooper Companies or RxSight?

In their latest fiscal years revenue changed by +5.1% at Cooper Companies and -3.9% at RxSight.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies